Form 4 for GH Guardant Health, Inc.
Accepted 2025-12-08 00:00:00 ET · period of report 2025-12-05 · accession 0001702824-25-000008 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-12-08 | 2025-12-05 | GH | Bell Michael Brian | CFO | M - OptEx | $30.71 | +56.3K | 81.5K | +223% | +$1.73M |
| DM | 2025-12-08 | 2025-12-05 | GH | Bell Michael Brian | CFO | S - Sale+OE | $103.14 | -80.4K | 57.9K | -58% | -$8.29M |
| DM | 2025-12-08 | 2025-12-05 | GH | Bell Michael Brian | CFO | M - OptEx | $0.00 | -56.3K | 7,137 | -89% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-12-05 | M | A | 26,905 | $28.37 | 108,414 | D | — | — | |
| 2 | Common | Common Stock | 2025-12-05 | S | D | 8,033 | $101.42 | 100,381 | D | — | — | (F1) Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $100.715 to $101.705. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range. |
| 3 | Common | Common Stock | 2025-12-05 | M | A | 29,382 | $32.86 | 81,509 | D | — | — | |
| 4 | Common | Common Stock | 2025-12-05 | S | D | 1,190 | $107.26 | 28,052 | D | — | — | (F11) Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $107.010 to $107.390. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range. |
| 5 | Common | Common Stock | 2025-12-05 | S | D | 3,284 | $106.70 | 29,242 | D | — | — | (F10) Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $105.935 to $106.925. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range. |
| 6 | Common | Common Stock | 2025-12-05 | S | D | 5,027 | $103.96 | 32,526 | D | — | — | (F9) Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $103.720 to $104.510. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range. |
| 7 | Common | Common Stock | 2025-12-05 | S | D | 2,533 | $103.24 | 37,553 | D | — | — | (F3) Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $102.720 to $103.710. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range. |
| 8 | Common | Common Stock | 2025-12-05 | S | D | 8,774 | $102.11 | 40,086 | D | — | — | (F8) Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $101.715 to $102.670. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range. |
| 9 | Common | Common Stock | 2025-12-05 | S | D | 3,267 | $101.46 | 48,860 | D | — | — | (F7) Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $100.710 to $101.700. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range. |
| 10 | Common | Common Stock | 2025-12-05 | S | D | 5,568 | $106.68 | 52,127 | D | — | — | (F6) Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $106.420 to $106.980. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range. |
| 11 | Common | Common Stock | 2025-12-05 | S | D | 250 | $105.82 | 57,695 | D | — | — | (F5) Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $105.415 to $106.390. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range. |
| 12 | Common | Common Stock | 2025-12-05 | S | D | 22,891 | $102.11 | 77,490 | D | — | — | (F2) Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $101.715 to $102.690. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range. |
| 13 | Common | Common Stock | 2025-12-05 | S | D | 7,567 | $103.26 | 69,923 | D | — | — | (F3) Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $102.720 to $103.710. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range. |
| 14 | Common | Common Stock | 2025-12-05 | S | D | 11,978 | $103.96 | 57,945 | D | — | — | (F4) Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $103.720 to $104.440. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range. |
| 15 | Derivative | Stock Option (Right to Buy) | 2025-12-05 | M | D | 26,905 | $0.00 | 10,421 | D | $28.37 · — to 2033-12-13 | 26,905 Common Stock | (F13) This represents a stock option granted on December 13, 2023 that vests over a three-year period. 33% of the shares subject to such award vested on October 1, 2024 and the remaining 67% of the shares vests in equal monthly installments over the remaining two-year period thereafter. |
| 16 | Derivative | Stock Option (Right to Buy) | 2025-12-05 | M | D | 29,382 | $0.00 | 7,137 | D | $32.86 · — to 2033-06-09 | 29,382 Common Stock | (F12) The stock option vests as to 33% of the shares subject to such award on June 9, 2024, and as to the remaining 67% of the shares subject to such award in substantially equity installments on each monthly anniversary of June 9, 2024, during the two-year period thereafter. |